Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

By Cunningham D.   James R.D.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 826-834

Elsevier

Access to resources Recommend Favorite

Oral Fluoropyrimidines in the Treatment of Advanced Colorectal Cancer: Results of Two Consecutive Phase II Trials

By Adimi Parvin   Hansen Flemming   Kjaer Mogens   Aabo Kristian   Keldsen Nina   Pfeiffer Per   Sandberg Erik   Jakobsen Anders  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 202-203

Informa Healthcare

Access to resources Recommend Favorite

Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer

By Tsuji Takashi   Sawai Terumitsu   Takeshita Hiroaki   Nakagoe Tohru   Hidaka Shigekazu   Yamaguchi Hiroyuki   Yasutake Toru   Nagayasu Takeshi   Tagawa Yutaka  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 531-536

Springer Publishing Company

Access to resources Recommend Favorite

Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells

By Hidaka S.   Yasutake T.   Fukushima M.   Yano H.   Haseba M.   Tsuji T.   Sawai T.   Yamaguchi H.   Nakagoe T.   Ayabe H.   Tagawa Y.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 975-980

Elsevier

Access to resources Recommend Favorite

Oral Tegafur and Folinic Acid for the Treatment of Advanced Colorectal Cancer

By Isla M.D.   Mayordomo J.I.   Cajal R.   Saenz A.   Escudero P.   Tres A.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 166-167

Elsevier

Access to resources Recommend Favorite